CMS Freezes Elevance Medicare Advantage Enrollment - What Does it Mean?

CMS has formally issued a Notice of Imposition of Intermediate Sanctions against Elevance Health, suspending new enrollment into certain Medicare Advantage Prescription Drug (MA-PD) contracts effective March 31, 2026, unless corrective action is completed before that date.

When I saw this, my first thought wasn’t shock.

It was: Here we go again.

Because after more than 15 years working in Medicare, I’ve learned something very clearly:

Medicare Advantage plans are extremely sensitive to regulatory and financial pressure. And when that pressure builds, disruption follows.

This situation is not a plan cancellation. It’s not a termination. Current members are not losing coverage.

But it is another reminder of how the Medicare Advantage machine actually works behind the scenes  – and why I spend so much time talking about structural stability.

Let’s walk through what happened.

What CMS Is Alleging - In Plain Terms

Medicare Advantage insurers are paid based on the health risk of their members. The more documented diagnoses a member has, the higher the payment from CMS. That system is called risk adjustment.

It is the financial backbone of Medicare Advantage.

According to CMS, between 2018 and 2025, Elevance identified diagnosis codes it believed may have been unsupported. However, CMS says Elevance submitted related information using encrypted USB drives rather than the electronic systems CMS requires (RAPS, EDPS, RAOR).

CMS states it repeatedly instructed Elevance to correct the submission method.

Elevance has said it updated its practices in April 2023 and stands behind its compliance process.

But CMS concluded the issue amounted to “substantial and persistent noncompliance.”

That’s serious language.

And when CMS uses that language, they act.

What This Sanction Actually Does

Let me be very clear here.

This is:

• Not a contract termination

• Not a plan shutdown

• Not a loss of benefits for current members

It is an enrollment suspension.

If the sanction takes effect:

• Elevance cannot accept new Medicare Advantage enrollees under the affected contracts

• Certain marketing activities may be restricted

• Current members stay enrolled

• Benefits remain intact

CMS has given Elevance until March 30, 2026, to submit corrections and a CEO-level attestation. If they do, this may be resolved.

But here’s the bigger issue.

CMS does not freeze enrollment over minor clerical disagreements.

When enrollment is frozen, it means regulators believe compliance failures are meaningful.

Why This Matters More Than It Looks

I see headlines calling this a “data submission dispute.”

That’s far too simple.

Risk adjustment is not a small administrative detail. It determines revenue. It determines margins. It determines plan design flexibility.

When risk coding practices are questioned, money is questioned.

And when money is questioned, everything tightens.

Over the past few years, I’ve watched:

• UnitedHealthcare shrinks certain Medicare Advantage footprints

• Humana scales back markets

• UCare exits the MA business in certain regions

• Supplemental benefits get trimmed

• RADV audits intensify

• CMS increases scrutiny on overpayments

This isn’t random.

The Medicare Advantage system is under financial and regulatory pressure.

And this Elevance situation fits directly into that pattern.

Who Could Feel This

If sanctions take effect, new enrollment into affected Elevance plans would be suspended.

That impacts:

• People turning 65

• Individuals with Special Enrollment Periods

• Beneficiaries moving into certain service areas

• Certain Special Needs Plan enrollments

Current members are not being dropped.

But I’ve seen enough of these situations to know that when regulators intervene, it introduces uncertainty – even if benefits don’t change immediately.

And uncertainty is what I try to help people avoid.

What Most Beneficiaries Never See

When someone sits down with me to talk about Medicare Advantage, they usually mention:

• $0 premium

• Dental benefits

• Vision coverage

• OTC allowances

• Gym memberships

Very few people ever ask about:

• Risk Adjustment Data Validation audits

• Coding intensity reviews

• Overpayment recovery rules

• CMS enforcement authority

• Annual federal contract renewals

But those are the mechanics that actually determine plan stability.

Medicare Advantage is not just an insurance product. It is a reimbursement structure built on the accuracy of risk scoring.

When compliance becomes an issue, the federal government steps in.

And when the federal government steps in, plans adjust.

That’s not opinion. That’s how the system is designed.

Why I Continue to Emphasize Medigap Stability

This is where the structural difference becomes obvious.

Medicare Advantage depends on:

• Risk-adjusted payments

• Diagnosis documentation that affects revenue

• Annual CMS contract renewals

• Regulatory compliance precision

Medigap doesn’t work that way.

Medicare Supplement plans are:

• Standardized by federal law

• Not paid based on diagnosis intensity

• Not subject to enrollment freezes tied to coding disputes

• Guaranteed renewable as long as premiums are paid

If you pay your premium, your policy stays in force.

With Medigap, you don’t deal with:

• Networks are shifting because of reimbursement disputes

• Benefit redesign every January

• Enrollment sanctions tied to backend compliance disputes

Is Medigap more expensive upfront? Often, yes.

But what you are buying is insulation from this exact kind of volatility.

You are stepping outside a reimbursement structure that constantly recalibrates.

As people age and healthcare usage increases, I’ve found predictability becomes more valuable than extra perks.

My Perspective After 15+ Years

Will Elevance likely resolve this? Possibly.

Will current members lose coverage? No.

But I don’t focus on individual incidents.

I focus on patterns.

And the pattern I see is this:

The Medicare Advantage system is financially engineered and regulator-sensitive. When pressure builds –  whether from audits, reimbursement adjustments, or compliance findings – disruption follows.

Sometimes it’s subtle.
Sometimes it’s dramatic.

But it’s recurring.

Some beneficiaries are comfortable with that trade-off.

Others prefer fewer moving parts in their healthcare coverage.

The key is understanding the structural differences before you need expensive care — not after.

This isn’t about panic. It isn’t about reacting to headlines.

It’s about awareness.

If you’re enrolled in a Medicare Advantage plan, take the time to truly understand:

• How is your plan funded

• How often can benefits change

• What role do networks play

• How prior authorization works

• What happens if regulatory action affects your carrier

If you have a Medigap plan, understand what protections you actually have and how guaranteed renewability works.

Every coverage structure has trade-offs.

The important thing is not assuming stability – but verifying it.

The more you understand how your plan works behind the scenes, the fewer surprises you’ll face later.

And in Medicare, fewer surprises are usually the goal.

Sources

Centers for Medicare & Medicaid Services. Notice of Imposition of Intermediate Sanctions – Elevance Health, February 27, 2026.
https://www.cms.gov/files/document/elevancehealthsanction02272026.pdf

Elevance Health. Form 8-K Filing, March 2, 2026.
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001156039/7588e928-0114-4226-a9bd-9c2ad5af80f3.pdf

42 C.F.R. § 422.326 — Reporting and Returning of Overpayments.
https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-422/subpart-G/section-422.326

42 C.F.R. § 422.752 — Basis for Imposition of Intermediate Sanctions.
https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-422/subpart-O